CCN2/CTGF expression has been reported in activated astrocytes in the brain of human patients with Alzheimer’s disease suggesting a potentially pathogenic role in astrogliosis and neuroinflammation [92]. Here, CCN2 is linked to early-onset autosomal dominant Alzheimer disease.